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Abstract
Urban rats present a global public health concern as they are considered a reservoir and vector of zoonotic pathogens,
including Escherichia coli. In view of the increasing emergence of antimicrobial resistant E. coli strains and the on-going
discussion about environmental reservoirs, we intended to analyse whether urban rats might be a potential source of
putatively zoonotic E. coli combining resistance and virulence. For that, we took fecal samples from 87 brown rats (Rattus
norvegicus) and tested at least three E. coli colonies from each animal. Thirty two of these E. coli strains were pre-selected
from a total of 211 non-duplicate isolates based on their phenotypic resistance to at least three antimicrobial classes, thus
fulfilling the definition of multiresistance. As determined by multilocus sequence typing (MLST), these 32 strains belonged
to 24 different sequence types (STs), indicating a high phylogenetic diversity. We identified STs, which frequently occur
among extraintestinal pathogenic E. coli (ExPEC), such as STs 95, 131, 70, 428, and 127. Also, the detection of a number of
typical virulence genes confirmed that the rats tested carried ExPEC-like strains. In particular, the finding of an Extended-
spectrum beta-lactamase (ESBL)-producing strain which belongs to a highly virulent, so far mainly human- and avian-
restricted ExPEC lineage (ST95), which expresses a serogroup linked with invasive strains (O18:NM:K1), and finally, which
produces an ESBL-type frequently identified among human strains (CTX-M-9), pointed towards the important role, urban
rats might play in the transmission of multiresistant and virulent E. coli strains. Indeed, using a chicken infection model, this
strain showed a high in vivo pathogenicity. Imagining the high numbers of urban rats living worldwide, the way to the
transmission of putatively zoonotic, multiresistant, and virulent strains might not be far ahead. The unforeseeable
consequences of such an emerging public health threat need careful consideration in the future.
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Introduction
Brown rats (Rattus norvegicus) are commensal rodents found in
urban areas worldwide. They are associated with hygienic
problems and are considered a reservoir and vector of several
zoonotic pathogens. Indeed, until the twentieth century, one of the
most feared diseases related to rats was the plague caused by
Yersinia pestis [1,2]. Nowadays, a number of other bacterial, viral
and parasitic pathogens have been associated with rats, such as
Leptospira spp., Shiga toxin producing E. coli, Campylobacter spp.,
Salmonella spp., or Hantaviruses [1,3,4,5,6]. There are numerous
ways, by which rodent-borne pathogens may infect human and
animal hosts. Inhalation of aerosols and consumption of contam-
inated food are considered the main pathways, while also direct
contact, e.g. by bites, or infections via vectors might occur. Even
surface water contaminated with droppings and urine from
infected rats in recreational areas has been identified as possible
infection source [7]. In addition, specific ecological and behavioral
characteristics, e.g. a concentration of Brown rats into high-density
populations along with their cohabitation with humans, may
further promote the spread of zoonotic pathogens [7].
Another aspect of Brown rats synanthropism is their inhabita-
tion of areas near anthropogenically created food sources, such as
garbage or sewage systems, also providing harborage [8,9].
Although it is well known that rats live in certain parts of the
sewage system [10], even continuous baiting programs have failed
to eliminate Brown rat populations [11]. Brown rats from rural
areas can roam as far as 260–2000 m within a day, while
observational studies in city environments identified smaller
activity areas of 25–150 m for rats in urban areas [10].
Nevertheless, urban Brown rats also appear to be able to build
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an epidemiological bridge between the sewage system and
populated urban environments, as social factors, such as aggres-
sion in case of overpopulation of rats [12] or large disturbances in
their environment can force populations to travel long distances
also [13]. This can lead to large population fluctuations and the
transmission of pathogens hosted by rats into new areas [14].
Although a natural fear of wild rats as putative carriers of
infectious agents is largely embedded in our culture [15], there are
hardly any scientific data regarding actual population trends.
Estimations about the number of animals are scant or not
available at all, like is also the case for our study site, Berlin. For
other comparable urban areas, the total number of Brown rats
seems to have been on a continuous high level over the last 50
years, as it has been reported for Baltimore (USA) [7]. But in
recent years, there have also been reports on increased levels of
infestation of urban areas in Great Britain [16]. At the same time,
there is evidence of substantial under-reporting of rat infestations
[10]. Furthermore, a deteriorating integrity of sewage infrastruc-
tures combined with less sewer baiting programs [10] may have
intensified the occasion of direct and indirect contact between rat
and humans in an urban environment. On a global level, climate
change and changing human settlement patterns like the ongoing
urbanization trend could lead to increased problems with rat-
borne pathogens as the distribution of rodent species and
pathogens linked to these species could be influenced [10].
Rats are natural hosts of Escherichia (E.) coli, a commensal
ubiquitous bacterium colonizing the gut of mammals and birds
[17]. Here, from a zoonotic perspective, intestinal pathogenic
subtypes of E. coli (InPEC), including Shiga toxin producing E. coli
(STEC), enterohemorrhagic E. coli (EHEC), enteroaggregative E.
coli (EaggEC), and extraintestinal pathogenic E. coli (ExPEC) are of
major concern. Recent studies on the occurrence of putatively
zoonotic E. coli in rats were largely focused on STEC and on the
epidemiologic relevance that rats, living on or in close proximity to
cattle farms, might play in the distribution of EHEC O157 isolates
[3,5,18]. Yet barely anything is known about the role of rats as
carriers of ExPEC, which have received large attention recent
years as they often express a multiresistance phenotype. In
particular Extended-spectrum beta-lactamase (ESBL)-producing
ExPEC strains account for serious problems in the treatment of
infectious diseases in humans and animals as these enzymes confer
resistance to nearly all beta-lactam antimicrobial drugs, including
third-generation cephalosporins [19,20,21,22,23]. Although ESBL
strains have been observed among all phylogenetic groups of E. coli
including ‘‘extraintestinal pathogenic groups’’ B2 and D, still a
larger proportion belongs to phylogenetic lineages and multilocus
sequence types (STs) that are composed of opportunistic pathogens
and commensals, lacking an extensive set of virulence-associated
genes and causing infections primarily in immuno-compromised
hosts [19,21]. A well-known exception is the worldwide emerging
clonal group O25b:H4-B2-ST131-CTX-M-15 which has been
implicated in a wide range of severe hospital- and community-
acquired extraintestinal infections in humans and animals [24].
The recent finding of an ESBL-producing E. coli strain belonging
to this pandemic group in the feces of an urban rat from Berlin
[22] prompted us to screen urban rats also for other multiresistant
E. coli, the presence of genes associated with extraintestinal
pathogenic and Shiga toxin producing strains, and their phyloge-
netic relatedness to human and animal clinical strains, determined
by multi locus sequence typing (MLST). As the simple possession
of virulence associated genes does not necessarily translate to
in vivo pathogenicity, we chose one exemplary isolate to assess its
pathogenicity in a chicken infection model. The strain was selected
as it harbored a frequently encountered ESBL type (CTX-M-9)
and represented a prominent and highly invasive ExPEC-lineage
(ST95), which so far has been particularly associated with
pathogenic human and avian strains and only scarcely expressed
a multiresistance phenotype. The data obtained here might help to
gain further insight into the role of synanthropic rodents as
carriers, reservoir and even disseminators of E. coli that combine
multiresistance and extraintestinal virulence.
Materials and Methods
Ethics Statement
All animal experiments were approved by the ‘‘Landesamt fuer
Gesundheit und Soziales’’ (Reg. 0220/06) and chickens were killed
according to animal welfare norms.
Bacterial Strains
Fecal samples of 87 urban brown rats (Rattus norvegicus) were
collected on 53 different sampling locations all over Berlin
(Germany) from 2008–2009. Rats were captured and euthanized
by pest control technicians during pest control (n = 40), or swabs
were taken directly at the place of capturing and transferred into
conservation medium (Mast Diagnostics, Reinfeld, Germany)
(n = 47). After overnight cultivation on ChromeOrientationH agar
(Mast Diagnostics) at 37uC, at least three E. coli isolates were
obtained from each fecal sample. Classical biochemical methods
were used to determine the bacterial species [25]. Copy clones
recovered from individual animals (copy clones among different
individuals were not detected), were excluded by randomly
amplified polymorphic DNA (RAPD)-PCR, performed as recently
described [26].
Determination of Phenotypic Resistance and Pre-
selection of Strains
Preliminary screening for antimicrobial resistance was done by
agar dilution test with six different antimicrobial substances as
recently described [27]. Here, freshly prepared Mueller–Hinton-
agarose plates containing estimated breakpoint concentrations of
ampicillin ($32 mg/ml), streptomycin ($64 mg/ml), spectinomy-
cin ($128 mg/ml), chloramphenicol ($32 mg/ml), gentamicin
($16 mg/ml) and tetracycline ($16 mg/ml) were used. Isolates
displaying phenotypic resistance for at least one antimicrobial class
were additionally tested by Agar broth microdilution method
(Micronaut breakpoint plate ‘‘Kleintier’’, Genzyme Diagnostics,
Ru¨sselsheim, Germany) against seventeen antimicrobials including
beta-lactams as well as non-beta-lactams like aminoglycosides,
tetracyclines, sulfonamides, chloramphenicol and fluoroquinolones
according to the standards given by the CLSI guideline [28].
Phenotypic screening for ESBL production was performed using
the confirmatory test with cefotaxime and ceftazidime alone or in
combination with clavulanic acid according to the method
recommended in the CLSI document M31-A3 [28].
Determination of Antimicrobial Resistance Genes
Multiresistant E. coli isolates were screened for the presence of
antimicrobial resistance genes, such as tet(A-D), sul1, sul2, sul3, strA,
strB, aadA1-like, aac(3)-IV, blaTEM-1-like, blaSHV and blaCTX-M using
standard PCR methods and sequencing of the PCR products if
necessary. The presence of plasmid-mediated quinolone resistance
gene variant aac(69)-Ib-cr and the qnrA, qnrB, and qnrS genes as well
as of mutations in gyrA and parC genes were determined by PCR
and, if indicated by sequence or restriction analysis
[29,30,31,32,33,34,35,36,37].
ESBL-ExPEC in Wild Rats
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Characterization of ESBL Producing Isolates
Self-transferability of plasmids was tested by mating experi-
ments using azid-resistant recipient E. coli strain J53 as previously
described [37]. Further characterization was performed by
southern blotting, PCR-based replicon typing and pulsed-field
gel electrophoresis (PFGE) using a CHEF DRIII System (BioRad,
Munich, Germany) for comparative analysis with clinical isolates
[37].
Multilocus Sequence Typing and Phylogenetic Grouping
Multilocus sequence typing (MLST) was carried out for the
multiresistant E. coli strains according to the scheme developed by
Wirth et al. (2006) [17]. Gene amplification and sequencing was
done by using primers specified at the E. coli MLST web site
(http://mlst.ucc.ie/mlst/mlst/dbs/Ecoli). Sequences were ana-
lyzed by the software package RidomSeqSphere (http://www.
ridom.de/) and STs were either computed automatically or newly
assigned in case novel STs have been identified. E. coli
phylogenetic groups were determined by Structure analysis based
on the concatenated sequences of the seven housekeeping genes
(http://pritch.bsd.uchicago.edu/structure).
Virulence Gene Typing
Multiresistant E. coli isolates were examined for the presence of
59 virulence-associated genes (VAGs) linked with extraintestinal
pathogenic and Shiga toxin producing E. coli by multiplex and
single PCRs as described previously [37]. VAGs determined
encode factors within the categories of toxins, adhesins, iron
aquisition systems, protectins and others (detailed information is
given in Fig. 1).
Chicken Infection Model
Based on phenotypic and genotypic resistance pattern, MLST
and virulence gene typing, one exemplary rat isolate (IMT20717;
O18:NM:K1; ST95; ST complex 95), resembling a highly virulent
ExPEC genotype and serogroup and additionally expressing a
CTX-M-9-type beta lactamase, was selected to assess it pathogenic
potential in vivo.
A chicken infection model [38], which has already been shown
to be appropriate for testing non-avian ExPEC strains as well [39]
was used. Four groups of six chickens each were infected intra-
tracheally with 109 colony-forming units (CFU) of the test strain
and two control strains, one low pathogenic avian fecal strain
(IMT12226; O77:H18; ST1165, STC144) as negative control and
archetypical E. coli strain RS218 (O18:H7:K1; ST95; STC95),
isolated from a case of meningitis in a baby, as positive control
strain [40]. This non-ESBL producing strain was included in order
to directly compare a clinical strain of the same phylogenetic
background and identical O- and K-antigens with the multiresis-
tant urban rat isolate.
Results and Discussion
High Isolation Rates of E. coli from Rats
E. coli isolates were recovered from 77.0% (n= 67) of the 87 rats
(R. norvegicus). Isolation from fresh fecal swabs (95%) seemed more
preferable than that from swabs taken to the laboratory in
conservation media (70%). Overall, the isolation rate is beyond
what has been described for other rodent fecal samples so far [41],
whereas it is similar to what has been found in a study including
wild R. rattus in Africa [42]. After picking at least three colonies per
animal, a total of 238 E. coli isolates were obtained. RAPD-PCR
analysis (data not shown) was further used to exclude isolates with
identical band profiles, which were only observed in individual
animals but not in-between rats. Finally, 211 non-duplicate strains
were included in further experiments and the reduction by a
number of only 27 copy strains indicated a quite high diversity
amongst rat E. coli isolates.
Frequent Occurrence of Multiresistant E. coli Isolates in
Rats
Several rat E. coli isolates showed phenotypic resistance to
ampicillin (15%), cephalothin (5%), as well as to fluoroquinolones
like enrofloxacin (7%), difloxacin (9%) and marbofloxacin (7%),
the two aminoglycosides gentamicin/kanamycin (both 5%),
tetracycline (16%), sulfamethoxazole-trimethoprim (9.4%), and
chloramphenicol (10%). A total of 55 of all 211 isolates (26%)
exhibited resistant phenotypes in the agar dilution test against at
least one antimicrobial class. According to MIC data, 32 of these
isolates showed resistance to three or more classes of antimicro-
bials (Table 1). Thus, following the definition given by Schwarz
et al. (2010) [43], overall 13.6% (n= 32) of E. coli strains isolated
from urban rats should be regarded multiresistant. Of these, two
(IMT19205 and IMT20717) showed a positive confirmatory test
for the production of ESBLs. One of these isolates (IMT19205)
belonged to the pandemic clonal group B2-ST131-O25b:H4 and
was included in a previous publication [22]. MIC testing of all 32
isolates revealed high rates of resistance to beta-lactams like
ampicillin (87.5%), oxacillin (96.9%), cephalothin (31.3%), as well
as to fluoroquinolones like enrofloxacin (43.8%), difloxacin (50%)
and marbofloxacin (43.8%), the two aminoglycosides gentamicin/
kanamycin (both 34.4%), tetracycline (84.4%), sulfamethoxazole-
trimethoprim (59.4%), and chloramphenicol (65.6%). The most
abundant pattern observed was combined resistance to ampicillin,
tetracycline and the fluoroquinolones (Table 1). Screening for
antimicrobial resistance determinants nearly always reflected the
phenotypic resistance situation. Most or all strains harboured
blaTEM-1-like (87.5%), sul1/sul2 (75%) and strA/B genes (100%),
whereas other non-beta-lactam resistance genes, such as aadA
(34.4%), tet(A–D) (25%), aac(3)IV (3.1%), aac(69)-Ib-cr (6.3%), and
qnrB1 (3.1%) were present in lower frequencies (Table 1).
In general, data on antimicrobial resistance in E. coli from wild
rats are rather limited. Literak et al. (2009) identified 2.5% of
African R. rattus isolates to be ESBL-producers [42]. An additional
study reported high rates of multiresistant E. coli in rats (R.
norvegicus) from a port in Greece [6]. Taking into account other
synanthropic wildlife species as well, the rates of antimicrobial
resistant E. coli detected in this study are higher than what has
been found in raccoons (16% from urban environments) [44] or
small mammals (15% in residential areas) [45]. The higher rates
obtained from urban rats could be explained by the assumption
that human activities including production of sewage are the most
likely common source of E. coli transmission to urban wildlife. As
only rats populate the sewage system directly, they have direct
contact with human feces, whether from private households or
clinics and might frequently take up multiresistant strains in this
way. The recent finding of comparable antimicrobial resistance
patterns in E. coli isolates from rats and humans agrees with this
[46,47]. Also, compared to rodents from rural areas in Central
Europe, the rates of multiresistant E. coli from urban rats seem to
be higher (13.6% vs. approx. 2%) [22,48]. One logical conclusion
could be that rats might serve as surrogate marker for the spread of
antimicrobial resistance in urban areas. Above all, however, their
potential to disseminate multiresistant microorganisms in highly
populated areas should not be obscured, especially since there is
almost no doubt about their ability to spread zoonotic pathogens
among humans and animals [3,4,5,49].
ESBL-ExPEC in Wild Rats
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High Diversity of Sequence Types (STs) Among
Multiresistant Rat Isolates Including STs Associated with
Extraintestinal Pathogenicity in Humans
Overall we determined a total of 24 different STs among the 32
multiresistant isolates out of which seven were assigned to
ancestral group B2 (ST95, ST131, ST127, ST428, ST1444,
ST1851, and ST2381), four to group D (ST38, ST70, 26ST501),
three to group B1 (ST88, ST2380, and ST2976), and two to group
A (ST10 and ST1286) (Tab.1). Another eleven and five STs
belonged to hybrid groups ABD (ST57, ST453, ST1011,
26ST64136ST1049, and 36ST1850), and AxB1 (26ST93,
ST224, and 26ST1849), respectively, which are supposed to
represent highly recombining groups that have gained genetic
material from different ancestral groups in the past [17]. More
than one third (34.5%) of multiresistant strains were allocated to
the ExPEC-linked phylogenetic groups B2 and D. This high rate is
quite surprising as the B2 group generally represents the minority
of ESBL-producing E. coli, when compared with the remaining
groups, which more frequently harbor antimicrobial resistances
[21,50,51]. Nevertheless, the ST131-O25b:H4 pandemic clonal
group also belongs to group B2 and its success might just hallmark
an ongoing development where B2 strains are becoming
increasingly multiresistant. Interestingly, ESBL-producing E. coli
isolate IMT20717 was a B2 strain affiliated to ST95, which
currently represents one of the key ExPEC lineages in humans
[52], accounting for about 10% of human ExPEC strains
deposited into the database (last access: 04.10.2012; http://mlst.
ucc.ie/mlst/mlst/dbs/Ecoli/). Human ST95 strains extensively
share virulence features with ST95 strains isolated from systemic
infections in poultry, and so far this phylogenetic lineage seemed to
be almost exclusively linked with these two species [17,39,52,53].
Although we neither have evidence nor epidemiologic support,
due to the high species linkage of ST95 strains the rat isolate
IMT20717 might have its primary source rather in a human or
bird individual than in the rat itself, supporting putatively ongoing
transmission cycles.
Frequent Occurrence of Virulence Genes Associated with
Extraintestinal Pathogenicity Among Multiresistant Rat
Isolates
None of the multiresistant E. coli strains harboured Shiga toxin
genes 1 and 2, nor did we detect genes encoding for adherence
factors intimin (eae) and bundle forming pili (bfp), among others
indicating the absence of STEC among the multiresistant rat
strains. So far, Shiga toxin producing E. coli, including EHEC
O157, have only been identified in samples from rats living in
close proximity to cattle farms or with access to feedlot-cattle water
tanks [5,18,54]. This epidemiologic link was definitely not given in
case of our sample material and our results were therefore quite
reasonable. In contrast, we frequently detected a number of
ExPEC-related genes, as shown in Fig. 1. Overall 17.2% of all
multiresistant rat strains harboured at least twenty VAGs (max. of
Figure 1. Distribution of virulence-associated genes among 32 multiresistant rat E. coli isolates. The following genes showed no positive
results and are not presented in the figure: bfp, bmaE, eae, eitC, focG, gafD, nfaE, pic, pks, puvA, stx1 and stx2.
doi:10.1371/journal.pone.0050331.g001
ESBL-ExPEC in Wild Rats





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ESBL-ExPEC in Wild Rats
PLOS ONE | www.plosone.org 5 November 2012 | Volume 7 | Issue 11 | e50331
31), most of these belonging to the B2 group and thus presenting
typical ExPEC strains.
Nearly all isolates harboured bacterial adhesin genes encoding
Type 1 (fimC)- and Curli fimbriae (csgA). Also the presence of
typical ExPEC-related adhesins, such as the heat-resistant
agglutinin [hrA (28.1%)], iron-regulated hemagglutinin [iha
(12.5%)], P-fimbriae [pap operon genes (9.4%–12.5%)], S-fimbriae
[sfa/foc (6.3%)], or a recently described ExPEC adhesin [ea/I
(18.8%) hinted towards the affiliation of a number of rat strains to
the group of ExPEC strains. Iron acquisition genes, such as chuA
(43.8%), fyuA, iroN, irp2 (all 37.5%), iucD (28.1%), iutA (40.6%), sitA
(78.1%), and sitDepisomal (46.9%), which are known to confer fitness
advantage and also invasive properties towards E. coli residing in
the gut or bladder of their host, under certain circumstances being
capable of causing infections at various extraintestinal sites
[55,56,57], were also frequently detected. The finding of protectin
genes like increased serum resistance gene iss (53.1%), and
invasion-associated K1-capsule encoding gene neuC (9.4%), as
well as of plasmid-located transfer [traT (56.3%)] and outer
membrane genes [ompT (43.8%)], all of which are highly
associated with the virulence of human and avian ExPEC strains
[52,58] substantiates our belief, that rats could frequently be
asymptomatically colonized by ExPEC-like strains and may thus
serve as a permanent source of zoonotic E. coli. The pathogenic
nature of a number of the strains isolated in the present study is
further supported by the detection of toxin genes, such as the
cytonecrotizing factor cnf (12.5%), secreted autotransporter toxin
sat (9.4%), vacuolating autotransporter toxin vat (9.4%), and
haemolysin operon genes hlyA and hlyC (9.4%), which are
particularly characteristic for uropathogenic E. coli [56]. Apart
from the K1-capsule, which is one of the main features of highly
invasive ExPEC strains, exemplified by a subgroup of avian
pathogenic E. coli (APEC) as well as by E. coli strains implicated in
new-born meningitis (NMEC), we also found other invasion-
related factors among the rat strains, including ibeA (9.4%), which
has a crucial role in the bacterial translocation of the blood brain
barrier epithelium and in vivo pathogenicity, as previously shown in
a rat meningitis and a chicken infection model [59,60].
Consistent with our results, recent publications attributed the
successful colonization of the healthy gut of humans, dogs, swine,
and poultry also to the presence of ExPEC-typical VAGs
[53,61,62,63] The frequent finding of multiresistant ExPEC-like
strains among rat samples, however, contradicts the paradigm
about an ultimate loss of bacterial fitness due to the maintenance
of antibiotic resistance in combination with high levels of virulence
[64]. This combination is considered one of the major drivers for
the international spread of ESBL clone O25b:H4-B2-ST131,
while there are also studies pointing out that this might be only one
side of the coin [21,65]. If virulence would be that decisive for the
emergence of antimicrobial resistant and highly virulent ExPEC
strains, one would expect other clonal groups, such as the B2-
ST95 lineage, which accumulates highly invasive, mostly human
and avian strains [17,39,52,53], to acquire a multiresistance
phenotype, by that amplifying its threat to human and animal
health. Though, as discussed earlier, so far only a marginal
proportion (4%) of all ST-complex 95 strains deposited on the
web-hosted database (http://mlst.ucc.ie/mlst/mlst/dbs/Ecoli/) or
reported in several publications harbors ESBL genes or simply a
multiresistant phenotype [21]. The more intriguing it was that we
identified an ST95 ESBL-producing strain (IMT20717; CTX-M-
9) among the rat isolates, which remarkably showed multiresis-
tance, frequent possession of virulence genes (n = 31) in a B2
phylogenetic background, and a serogroup (O18:NM:K1) typical
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Figure 2. Dendrogram of ST95-ESBL rat strain IMT20717 with E. coli ST95-K1 strains. The clonal relationship shown is based on XbaI-
generated PFGE profiles. NM=non motile (H antigen negative or not expressed); NBM=newborn meningitis; UTI = urinary tract infection,
optimization 1.0%, position tolerance 1.5%.
doi:10.1371/journal.pone.0050331.g002
Figure 3. Results of the ST95-ST95 ESBL rat strain IMT20717 in the chicken infection model. Ability of B2-ST95-O18:NM:K1-CTX-M-9
urban rat strain IMT20717 to colonize the lungs, disseminate into internal organs and penetrate the blood brain barrier 24 h post intra-tracheal
infection (109 CFU) of a group of six 5-weeks old SPF White Leghorn chickens. Non-ESBL-producing NMEC strain RS218 (B2-ST95-O18:H7:K1) and avian
fecal strain IMT12226 (ST1165-O77:H18), known invasive and low pathogenic strains, were used as controls.
doi:10.1371/journal.pone.0050331.g003
ESBL-ExPEC in Wild Rats
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very much resembles isolates causing urosepsis and new born
meningitis in humans, and septicemia in chickens. Due to its
observed lifestyle in the rat, namely asymptomatically colonizing
the gut, it was reasonable to deduce the strains extraintestinal
pathogenicity not simply from its phylogenetic background and
the possession of several VAGs, but also experimentally in an
in vivo model. We made use of chicken experiments as this has
been shown a proper model for determining the pathogenicity of
ExPEC strains, in particular of ST95 strains, which are highly
linked to chickens as one of their natural hosts [39].
Paradigmatic Combination of Multiresistance and
Extraintestinal Pathogenicity in Urban Rat ST95-CTX-M-9-
producing Strain IMT20717
IMT20717 displayed a positive confirmatory test for the
production of ESBL. Apart from a blaCTX-M-9 gene, this strain
also harboured resistance genes blaTEM-1, sul2, strA, strB, aac(69)-Ib-
cr and aadA. All these genes, except for sul2, were located on a self-
transferable, approximately 50 kb plasmid of the N/FIC replicon
type.
Serotyping characterized IMT20717 as O18:NM:K1. Thereby
the strain expressed a combination of an O-antigen and a capsule
type which is highly linked with a clonal group of E. coli strains
frequently involved in invasive infections in humans
[19,39,58,59,66]. Particular attention has been drawn to E. coli
O18:K1 NMEC strains causing meningitis in babies shortly after
delivery. In addition, this serogroup is also frequent among avian
pathogenic E. coli (APEC). Here, it causes often fatal septicemia
and is responsible for great losses in poultry breeding [39,52,66].
Macrorestriction analysis and subsequent PFGE revealed a high
genetic similarity (Dice similarity $ 82.2%) between the rat B2-
ST95-O18:NM:K1-CTX-M-9 isolate and clinical ST95 strains of
different ExPEC pathovars, and an additional fecal strain from the
gut of a healthy human, all affiliated to this globally distributed
lineage (Fig. 2). This similarity strongly resembles what is already
well known, in that, the healthy human gut serves as a reservoir for
these pathovars [61]. The detection of a pathogenic strain linked
to human clinical environments points towards a possible
transmission pathway through clinic waste into the urban sewage
system.
In the in vivo infection model IMT20717 revealed a lower
bacterial recovery rate from chicken organs than the clinical
NMEC type strain RS218 (Fig. 3), which was included for
comparative purposes. Nevertheless the strain could be isolated
from all internal organs in significantly higher numbers than the
low pathogenic avian control strain IMT12226. Particularly its re-
isolation from the brain is of high indicative value for its invasive
potential (Fig. 3) as it suggests that the strain is able to penetrate
the blood brain barrier. In view of this, the finding of an ST95
strain in the gut of a rat could add rats to the list of potential hosts
for highly extraintestinal pathogenic E. coli as well. What is even
more disturbing is the fact that this strain carried an ESBL-
encoding plasmid. Such a combination, namely ESBL-ST95- E.
coli, has only rarely been observed in human clinical samples so far
[21] and its detection in wild rat is the first description of such a
superbug in an animal.
Conclusions
The urban rats examined in this study frequently carried
multiresistant E. coli strains showing high levels of resistance to
critically important antimicrobials like fluoroquinolones and ß-
lactams. As the WHO classified urban rats as a significant public
health threat [2] the data reported here might have yet
unpredictable consequences in the future. In particular, the
finding of an ESBL-producing ExPEC strain belonging to one of
the most virulent ExPEC lineages (ST95) might signify a new
development in the field of antimicrobial resistance, in that ESBL
plasmids step by step could find their way into highly virulent E.
coli populations. There is still no final clue for the recent
dominance of the pandemic B2-ST131-O25b:H4-CTX-M-15
clonal group. Several non-resistance-related attributes like bacte-
rial fitness, virulence patterns or insertional modifications in
fimbrial genes have been discussed as putative causes [65,67,68].
Taking into account the virulence potential of ST95, which is
believed to be comparably high to that of ST131, it remains
unclear why ST95 is far from being as broadly distributed as
ESBL-producing ST131. However, the urban rat-derived B2-
ST95-O18:NM:K1-CTX-M-9 strain possesses a number of
genetic markers whose products confer adhesive, toxic and
invasive properties and thus meets all requirements for a successful
commensal and extraintestinal pathogenic life style. Future
monitoring of clinical and environmental ESBL E. coli isolates
should therefore clarify whether the detection of this ST95-ESBL
strain from a rat simply presents an accidental finding of a minor
important ESBL clone in a single animal, or whether it points
towards a successful spread of ST95-ESBL outside the clinics as
well. In any case, this strain hallmarks the main finding of this
study: the mere occurrence of E. coli strains in urban rats that are
multiresistant & virulent is an alarming observation, as infections
with such strains could lead to severe clinical outcomes, leaving
only limited treatment options.
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